The world's first radiation dose imaging system is poised to impact radiotherapy

OnQ Prostate will empower 3T MRI at Belfair's radiologists to provide highly accurate and confident prostate cancer interpretations, powered by the latest advancement in diffusion MRI

The CEO Publication Acknowledges Jeff Timbrook's Leadership in Revolutionizing Cancer Screening

Uniquely suited for the mobile environment, Thynk Health offers the ability to manage and track complex medical care to increase accessibility of screening

First AI-assisted handheld ultrasound tool to increase diagnostic confidence at the bedside, just in time for COVID-19

The first AI-assisted hand-held tool to increase diagnostic confidence at the bedside

Using advanced machine learning to improve AR recovery resulted in a 60% reduction in write-offs reported in recent pilot

The European reprocessed medical devices market is expected to achieve around 14% CAGR up to 2025, on account of growing awareness amongst clinicians and doctors regarding improvised reprocessed medical devices.

Asia Pacific apheresis equipment market revenue surpassed USD 606 million in 2018 and is set to achieve significant CAGR from 2019 to 2025, driven by increasing incidence of blood related disorders in emerging economies.

Administrative Law Judge (ALJ) presiding over Jubilant Radiopharma's case at the United States International Trade Commission (ITC) found that Jubilant Radiopharma's importation and sale of RUBY-FILL Generators and RUBY Elution Systems in the United States does not violate section 337 of the Tariff Act of 1930.

Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK). The first 'Breakthrough Device Designation' received by Concept Medical Inc. was on 30th April 2019 for its MagicTouch SCB, for the treatment of Coronary Artery Disease (CAD) in patients with in-stent restenosis.

Visit Us At SIIM - Booth #219

Advanced Radiology's Chief Mammography Technologist recognized for leadership
in patient care innovation and staff development